Low levels of amyloid-β and tau proteins, biomarkers of Alzheimer’s disease (AD), in eye fluid were significantly associated with low cognitive scores, according to a new study published in the Journal of Alzheimer’s Disease. Led by researchers at Boston Medical Center, the study is the first to connect these known AD protein biomarkers in the […]Continue Reading ...
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy eating plan, getting more exercise, avoiding tobacco and managing known risk factors are among the key recommendations in the 2019 Primary Prevention of Cardiovascular Disease guideline from the American College of Cardiology (ACC) and […]Continue Reading ...
High magnification micrograph of Crohn’s disease. Biopsy of esophagus. H&E stain. Credit: Nephron/Wikipedia A new technique using patients’ own modified cells to treat Crohn’s disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months. Researchers at the NIHR […]Continue Reading ...
A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative (DNDi). Chagas disease affects an estimated […]Continue Reading ...
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome (HGPS). Moreover, the results, published in EMBO Molecular Medicine, identify a potential therapeutic target for this severe genetic disease, which is characterized […]Continue Reading ...
High magnification micrograph of Crohn’s disease. Biopsy of esophagus. H&E stain. Credit: Nephron/Wikipedia The largest study ever to look at why an expensive and commonly used group of drugs fails patients with Crohn’s disease has concluded that standardised drug doses are often too low. A UK wide collaboration led by the University of Exeter and […]Continue Reading ...
Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency (CVID). Therapeutically targeting these B cells improved the lung disease in all patients they treated. This was the largest study ever conducted for treatment of CVID […]Continue Reading ...
UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder. “This molecule is widely regarded as one of the top therapeutic targets for Parkinson’s disease, but this is the first convincing […]Continue Reading ...
Credit: CC0 Public Domain Researchers at the Lions Eye Institute (LEI) and The University of Western Australia have pioneered a study of the world’s first and only laboratory model of a rare type of retinal disease, paving the way for new treatment pathways. Cone dystrophy with supernormal rod response (CDSRR) is an inherited disease which […]Continue Reading ...
A major new study from the UC Davis Alzheimer’s Center has uncovered dramatic differences in the brains of Hispanics with a dementia diagnosis compared with those of non-Hispanic whites and of African Americans. The first-of-its-kind study, based on extensive analyses of autopsied brains, found that Hispanics diagnosed with dementia were much more likely to have […]Continue Reading ...
Credit: Louisiana State University Dr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward Fogarty, Chairman of Radiology at the University of North Dakota School of Medicine, report the first PET scan-documented case of improvement in brain metabolism in Alzheimer’s disease in a patient […]Continue Reading ...
It’s no secret that our genes are what makes us… us! But genes are often also the basis for debilitating diseases. One of the major clues to understanding any illness is seeing which genes are acting unusually during disease onset. But it’s not often clear if unusual gene activity is unique to the disease at […]Continue Reading ...
What do your genes say about your ischemic heart disease risk? This study is examining genes to see which ones might contribute to ischemic heart disease risk. To participate in this study, you must be a nonsmoker between ages 45 and 65. This study is located in Bethesda, Maryland. Are you an adult who takes […]Continue Reading ...
Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and valvular heart disease. “If proven […]Continue Reading ...
Data from an ongoing study found that women who had experienced frequent weight fluctuations had more risk factors for heart disease.Continue Reading ...
- Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
- Smoking may limit body’s ability to fight dangerous form of skin cancer
- Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
- TGen and ABL sign agreement to distribute new TB test technology
- UCD researchers lead development of new urine test to detect prostate cancer
- Miniature brains that can move muscles, grown in the lab
- Servier and Oncodesign announce research and drug development partnership
- FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
- TB Medicine Pretomanid Enters Regulatory Review Process in the United States
- Breastfeeding can erase effects of prenatal violence for newborns
- Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
- Space worries – shingles affecting astronauts says NASA
- Study shows how AI can improve physicians’ diagnostic accuracy
- Dolomite Bio launches new scRNA-Seq Reagent Kit at AGBT 2019
- World’s oldest semen viable for artificial insemination
- FDA Approves Zulresso (brexanolone) for the Treatment of Post-Partum Depression
- How it manipulates us to tribalism
- How can doctors encourage patients to adopt healthier behaviors?
- Meet Hal: He's One Sick Robot
- Blood test and mathematical model can estimate preterm birth rate in low-resource countries